Nu Skin Enterprises Inc (NUS)

NYSE
Currency in USD
7.68
-0.09(-1.16%)
Closed·
After Hours
7.96+0.28(+3.65%)
·
NUS Scorecard
Full Analysis
Net income is expected to grow this year
NUS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.677.86
52 wk Range
5.3212.65
Key Statistics
Edit
Prev. Close
7.77
Open
7.75
Day's Range
7.67-7.86
52 wk Range
5.32-12.65
Volume
355.5K
Average Volume (3m)
623.67K
1-Year Change
-36.27%
Book Value / Share
15.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NUS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Nu Skin Enterprises Inc News & Analysis

Show more

Nu Skin Company Profile

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Nu Skin Enterprises Inc Earnings Call Summary for Q1/2025

  • Nu Skin's Q1 2025 adjusted EPS of $0.23 beat $0.15 forecast; revenue reached $364.5M, surpassing $354.28M estimate; stock up 7.13% after-hours
  • Company reduced outstanding debt to $239M, lowest in over a decade; plans global launch of new wellness platform Prism IO by mid-2026
  • Q2 2025 guidance: revenue $355M-$390M, EPS $0.20-$0.30; preparing to enter Indian market with 'enormous mid to long term potential'
  • Challenges: macroeconomic pressures, gross margin decline to 67.8%, competitive market, potential supply chain and regulatory hurdles
  • InvestingPro analysis shows 'Fair' financial health (2.13 score), strong in relative value (4.37) and cash flow (2.72)
Last Updated: 09/05/2025, 00:32
Read Full Transcript

Compare NUS to Peers and Sector

Metrics to compare
NUS
Peers
Sector
Relationship
P/E Ratio
−9.8x−114.0x11.7x
PEG Ratio
0.011.430.03
Price/Book
0.5x2.2x1.5x
Price / LTM Sales
0.2x1.7x0.9x
Upside (Analyst Target)
−2.3%0.0%19.3%
Fair Value Upside
Unlock32.5%12.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.78%
Dividend Yield
3.13%
Industry Median 2.16%
Annualised payout
0.24
Paid quarterly
5-Years Growth
-30.55%
Growth Streak

Earnings

Latest Release
May 08, 2025
EPS / Forecast
0.23 / 0.15
Revenue / Forecast
364.50M / 354.28M
EPS Revisions
Last 90 days

Nu Skin (NUS) Income Statement & Profits

People Also Watch

41.34
RHI
-2.08%
36.81
IAC
-1.05%
42.10
G
-2.50%
25.06
MUR
-1.10%
326.96
LAD
-0.06%

FAQ

What Is the Nu Skin (NUS) Share Price Today?

The live Nu Skin share price today is 7.68.

What Stock Exchange Does Nu Skin (NUS) Trade On?

Nu Skin is listed and trades on the New York Stock Exchange stock exchange.

What Is the Ticker (Stock Symbol) for Nu Skin?

The stock symbol (also called a 'ticker') for Nu Skin is "NUS."

Does Nu Skin Pay Dividends? What’s The Current NUS Dividend Yield?

Yes, NUS Pays Dividends to its Shareholders. The current Nu Skin dividend yield is 3.13%.

What Is the Current Nu Skin Market Cap?

As of today, Nu Skin market capitalisation is 379.49M.

What Is Nu Skin's (NUS) Earnings Per Share (TTM)?

The Nu Skin EPS -0.78 (Trailing Twelve Months).

When Is the Next Nu Skin Earnings Date?

Nu Skin's next earnings report will be released on 29 Jul 2025.

Is NUS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Nu Skin moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nu Skin Stock Split?

Nu Skin has split 0 times. (See the NUS stock split history page for full effective split date and price information.)

How Many Employees Does Nu Skin Have?

Nu Skin currently has 3100 employees.

What is the current trading status of Nu Skin (NUS)?

As of 19 Jun 2025, Nu Skin (NUS) is trading at a price of 7.68, with a previous close of 7.77. The stock has fluctuated within a day range of 7.67 to 7.86, while its 52-week range spans from 5.32 to 12.65.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.